ES2375406T3 - Sonda y cebador para la detección de bacilos tuberculosos, y procedimiento para la detección de bacilos tuberculosos humanos con el uso de los mismos. - Google Patents
Sonda y cebador para la detección de bacilos tuberculosos, y procedimiento para la detección de bacilos tuberculosos humanos con el uso de los mismos. Download PDFInfo
- Publication number
- ES2375406T3 ES2375406T3 ES05734679T ES05734679T ES2375406T3 ES 2375406 T3 ES2375406 T3 ES 2375406T3 ES 05734679 T ES05734679 T ES 05734679T ES 05734679 T ES05734679 T ES 05734679T ES 2375406 T3 ES2375406 T3 ES 2375406T3
- Authority
- ES
- Spain
- Prior art keywords
- oligonucleotide
- nucleic acid
- primer
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 169
- 238000001514 detection method Methods 0.000 title claims description 69
- 201000008827 tuberculosis Diseases 0.000 title description 20
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 202
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims abstract description 179
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 144
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 107
- 230000000295 complement effect Effects 0.000 claims abstract description 45
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 45
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims abstract description 6
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims abstract description 6
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims abstract description 6
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229930024421 Adenine Natural products 0.000 claims abstract description 3
- 229960000643 adenine Drugs 0.000 claims abstract description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229940104302 cytosine Drugs 0.000 claims abstract description 3
- 229940113082 thymine Drugs 0.000 claims abstract description 3
- 229940035893 uracil Drugs 0.000 claims abstract description 3
- 239000000523 sample Substances 0.000 claims description 234
- 238000003752 polymerase chain reaction Methods 0.000 claims description 144
- 239000000126 substance Substances 0.000 claims description 64
- 238000002372 labelling Methods 0.000 claims description 59
- 102000039446 nucleic acids Human genes 0.000 claims description 37
- 108020004707 nucleic acids Proteins 0.000 claims description 37
- 239000000047 product Substances 0.000 claims description 34
- 239000000975 dye Substances 0.000 claims description 29
- 238000001962 electrophoresis Methods 0.000 claims description 28
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000007850 fluorescent dye Substances 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- 238000005227 gel permeation chromatography Methods 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 239000013615 primer Substances 0.000 description 219
- 108020004414 DNA Proteins 0.000 description 158
- 102000053602 DNA Human genes 0.000 description 158
- 238000006243 chemical reaction Methods 0.000 description 50
- 238000003753 real-time PCR Methods 0.000 description 45
- 241000186363 Mycobacterium kansasii Species 0.000 description 40
- 241000186367 Mycobacterium avium Species 0.000 description 37
- 241000186364 Mycobacterium intracellulare Species 0.000 description 36
- 230000003321 amplification Effects 0.000 description 33
- 238000003199 nucleic acid amplification method Methods 0.000 description 33
- 239000000243 solution Substances 0.000 description 31
- 239000003550 marker Substances 0.000 description 27
- 230000001580 bacterial effect Effects 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 16
- 241000187476 Mycobacterium triviale Species 0.000 description 16
- 238000003786 synthesis reaction Methods 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 15
- 238000011088 calibration curve Methods 0.000 description 15
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- 239000002751 oligonucleotide probe Substances 0.000 description 14
- 238000003745 diagnosis Methods 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- 241000186359 Mycobacterium Species 0.000 description 12
- 239000002773 nucleotide Substances 0.000 description 12
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 11
- 241000193830 Bacillus <bacterium> Species 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 11
- 239000000872 buffer Substances 0.000 description 11
- 238000009396 hybridization Methods 0.000 description 11
- 241000187491 Mycobacterium nonchromogenicum Species 0.000 description 10
- 239000012634 fragment Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 108010006785 Taq Polymerase Proteins 0.000 description 9
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 9
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 9
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 9
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 9
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 9
- 208000027531 mycobacterial infectious disease Diseases 0.000 description 9
- 241000894007 species Species 0.000 description 9
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 9
- 241000186365 Mycobacterium fortuitum Species 0.000 description 8
- 241000187492 Mycobacterium marinum Species 0.000 description 8
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 229910001629 magnesium chloride Inorganic materials 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 8
- 241001508003 Mycobacterium abscessus Species 0.000 description 7
- 241000187478 Mycobacterium chelonae Species 0.000 description 7
- 206010071401 Mycobacterium chelonae infection Diseases 0.000 description 7
- 241000187485 Mycobacterium gastri Species 0.000 description 7
- 241000187484 Mycobacterium gordonae Species 0.000 description 7
- 241000187490 Mycobacterium scrofulaceum Species 0.000 description 7
- 241000187489 Mycobacterium simiae Species 0.000 description 7
- 241000187496 Mycobacterium szulgai Species 0.000 description 7
- 241000187495 Mycobacterium terrae Species 0.000 description 7
- 241000187494 Mycobacterium xenopi Species 0.000 description 7
- 229920004890 Triton X-100 Polymers 0.000 description 7
- 239000013504 Triton X-100 Substances 0.000 description 7
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 7
- 229960005542 ethidium bromide Drugs 0.000 description 7
- 239000002987 primer (paints) Substances 0.000 description 7
- 229920002477 rna polymer Polymers 0.000 description 7
- 241000304886 Bacilli Species 0.000 description 6
- 238000007400 DNA extraction Methods 0.000 description 6
- 241000168058 Mycobacterium peregrinum Species 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 4
- 101710098119 Chaperonin GroEL 2 Proteins 0.000 description 4
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
- 102100034343 Integrase Human genes 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical group O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- QCPFFGGFHNZBEP-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 QCPFFGGFHNZBEP-UHFFFAOYSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000012869 ethanol precipitation Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000011895 specific detection Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 239000006173 Good's buffer Substances 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- 101100131080 Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) mpb70 gene Proteins 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 108091028733 RNTP Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 229960002319 barbital Drugs 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 238000010876 biochemical test Methods 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000002153 concerted effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000037029 cross reaction Effects 0.000 description 2
- 238000003748 differential diagnosis Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- -1 etc.) Proteins 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000000138 intercalating agent Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000011017 operating method Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000002205 phenol-chloroform extraction Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 101000917568 Drosophila melanogaster Fasciclin-3 Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241001536374 Indicator indicator Species 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 241000187482 Mycobacterium avium subsp. paratuberculosis Species 0.000 description 1
- 241000186366 Mycobacterium bovis Species 0.000 description 1
- 241000187493 Mycobacterium malmoense Species 0.000 description 1
- 101710181935 Phosphate-binding protein PstS 1 Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 108010033826 ribosomal protein S1 Proteins 0.000 description 1
- 101150007503 rps1 gene Proteins 0.000 description 1
- 101150008822 rpsA gene Proteins 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 238000011120 smear test Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical class [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000000814 tuberculostatic agent Substances 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004129272 | 2004-04-26 | ||
| JP2004129272 | 2004-04-26 | ||
| PCT/JP2005/007700 WO2005103249A1 (ja) | 2004-04-26 | 2005-04-22 | 結核菌検出用プライマー及びプローブ、並びにこれを用いたヒト型結核菌の検出方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2375406T3 true ES2375406T3 (es) | 2012-02-29 |
Family
ID=35196975
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10174146.0T Active ES2560433T3 (es) | 2004-04-26 | 2005-04-22 | Cebadores para la detección del bacilo de la tuberculosis y procedimiento de detección del bacilo de la tuberculosis humana con los mismos |
| ES05734679T Active ES2375406T3 (es) | 2004-04-26 | 2005-04-22 | Sonda y cebador para la detección de bacilos tuberculosos, y procedimiento para la detección de bacilos tuberculosos humanos con el uso de los mismos. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10174146.0T Active ES2560433T3 (es) | 2004-04-26 | 2005-04-22 | Cebadores para la detección del bacilo de la tuberculosis y procedimiento de detección del bacilo de la tuberculosis humana con los mismos |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8044184B2 (ja) |
| EP (2) | EP2256218B1 (ja) |
| JP (1) | JP4905130B2 (ja) |
| CN (3) | CN102329880B (ja) |
| AT (1) | ATE534749T1 (ja) |
| ES (2) | ES2560433T3 (ja) |
| WO (1) | WO2005103249A1 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007129628A1 (ja) * | 2006-05-02 | 2007-11-15 | Wako Pure Chemical Industries, Ltd. | マイコバクテリウム・イントラセルラーレ検出用プライマー及びプローブ、並びにこれを用いたマイコバクテリウム・イントラセルラーレの検出方法 |
| US8652782B2 (en) * | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| ES2650066T3 (es) * | 2008-05-28 | 2018-01-16 | Wako Pure Chemical Industries, Ltd. | Cebador y sonda para la detección de Mycobacterium intracellulare, y método para la detección de Mycobacterium intracellulare empleando el cebador o la sonda |
| KR101458781B1 (ko) * | 2009-08-26 | 2014-11-07 | 주식회사 엘지생명과학 | 결핵균군 및 마이코박테리아 속 구분 검출용 조성물 및 이를 이용한 실시간 다중 중합효소 연쇄반응에 의한 결핵균 및 마이코박테리아 속의 동시 분석 방법 |
| EP2582839B1 (en) * | 2010-06-21 | 2016-05-18 | Life Technologies Corporation | Compositions, methods and kits for nucleic acid synthesis and amplification using rt |
| WO2012002598A1 (ko) * | 2010-07-02 | 2012-01-05 | (주)바이오니아 | 결핵 진단용 프라이머, 프로브, 이를 포함하는 키트 및 상기 키트를 이용한 결핵 진단 방법 |
| US10265585B2 (en) | 2010-12-03 | 2019-04-23 | Sumitomo Rubber Industries, Ltd. | Golf ball |
| CN103911365A (zh) * | 2014-03-13 | 2014-07-09 | 南京爱必梦生物材料有限公司 | 提取结核杆菌dna的方法及检测其多重耐药性的试剂盒 |
| BR112017001500A2 (pt) | 2014-07-24 | 2018-02-20 | Abbott Molecular Inc | composições e métodos para a detecção e análise de tuberculose por micobactéria |
| CN108184327A (zh) | 2015-07-14 | 2018-06-19 | 雅培分子公司 | 用于鉴定耐药性结核的组合物和方法 |
| EP3485012A4 (en) * | 2016-07-15 | 2020-03-25 | Northwestern University | COMPOSITIONS AND METHODS FOR DETECTING NUCLEIC ACIDS IN EXPECTORATIONS |
| CN110475863B (zh) * | 2017-01-19 | 2023-10-13 | 株式会社钟化 | 用于检测堪萨斯分枝杆菌的引物组、探针、试剂盒及方法 |
| CN110819726B (zh) * | 2018-08-08 | 2023-12-05 | 台达电子工业股份有限公司 | 检测分枝杆菌的方法及其套组 |
| US11174520B2 (en) | 2018-02-27 | 2021-11-16 | Delta Electronics, Inc. | Method for detecting presence or absence of Mycobacterium and kit thereof |
| TWI677578B (zh) * | 2018-02-27 | 2019-11-21 | 台達電子工業股份有限公司 | 檢測結核分枝桿菌的方法及其套組 |
| EP4079851A4 (en) * | 2019-12-18 | 2023-06-07 | FUJIFILM Corporation | SET OF PRIMERS FOR DETECTING MYCOBACTERIUM TUBERCULOSIS, MYCOBACTERIUM AVIUM AND MYCOBACTERIUM INTRACELLULARE, METHOD USING THE SAME, AND ASSOCIATED REAGENT KIT |
| US11965217B2 (en) * | 2020-07-21 | 2024-04-23 | Delta Electronics, Inc. | Method and kit for detecting Mycobacterium tuberculosis |
| CN115927686A (zh) * | 2022-12-06 | 2023-04-07 | 潍坊医学院 | 一种用于检测结核与非结核分枝杆菌的引物探针组合物及试剂盒和检测方法 |
| CN115948506B (zh) * | 2022-12-21 | 2024-07-09 | 四川大学华西医院 | 检测非结核分枝杆菌耐药基因及变异的探针库及试剂盒 |
| CN118460753A (zh) * | 2024-07-12 | 2024-08-09 | 江苏为真生物医药技术股份有限公司 | 用于诊断结核分枝杆菌感染的核酸标志物的检测剂及其应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5840099A (ja) | 1981-07-17 | 1983-03-08 | アモコ・コ−ポレ−ション | 光−放射ポリヌクレオチドの交雑診断方法 |
| CA1180647A (en) | 1981-07-17 | 1985-01-08 | Cavit Akin | Light-emitting polynucleotide hybridization diagnostic method |
| EP0107110B1 (en) | 1982-09-30 | 1987-04-22 | Aktiebolaget Iro | Yarn storing, feeding and measuring device |
| WO1984003285A1 (en) | 1983-02-22 | 1984-08-30 | Molecular Biosystems Inc | Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis |
| JPS60281A (ja) | 1984-05-18 | 1985-01-05 | 松下冷機株式会社 | 断熱箱体 |
| ZA871554B (en) | 1986-03-05 | 1987-12-30 | Molecular Diagnostics Inc | Detection of microroganisms in a nucleic acid containing sample |
| US5348855A (en) | 1986-03-05 | 1994-09-20 | Miles Inc. | Assay for nucleic acid sequences in an unpurified sample |
| JP2650159B2 (ja) | 1988-02-24 | 1997-09-03 | アクゾ・ノベル・エヌ・ベー | 核酸増幅方法 |
| CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
| DK0490951T3 (da) * | 1989-09-06 | 1996-08-26 | Pasteur Institut | Nucleinsyrefragmenter fra en genom fra en egnet mycobakterie, deres anvendelse til diagnose af mycobakterieinfektioner samt plasmider indeholdende disse fragmenter |
| US5776693A (en) * | 1990-06-08 | 1998-07-07 | Institut Pasteur | Specific detection of the mycobacterium tuberculosis |
| FR2663033B1 (fr) | 1990-06-08 | 1992-09-04 | Pasteur Institut | Detection specifique du mycobacterium tuberculosis. |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5168039A (en) | 1990-09-28 | 1992-12-01 | The Board Of Trustees Of The University Of Arkansas | Repetitive DNA sequence specific for mycobacterium tuberculosis to be used for the diagnosis of tuberculosis |
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
| US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| US5470723A (en) | 1993-05-05 | 1995-11-28 | Becton, Dickinson And Company | Detection of mycobacteria by multiplex nucleic acid amplification |
| US5652106A (en) | 1993-06-04 | 1997-07-29 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Rapid amplification-based subtyping of mycobacterium tuberculosis |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| US5629179A (en) * | 1995-03-17 | 1997-05-13 | Novagen, Inc. | Method and kit for making CDNA library |
| US5801155A (en) * | 1995-04-03 | 1998-09-01 | Epoch Pharmaceuticals, Inc. | Covalently linked oligonucleotide minor grove binder conjugates |
| US5731150A (en) | 1995-11-01 | 1998-03-24 | Chiron Diagnostic Corporation | IS6110 based molecular detection of mycobacterium tuberculosis |
| US6465638B2 (en) | 1997-06-25 | 2002-10-15 | Ortho-Clinical Diagnostics, Inc. | Multiplexed PCR assay for detecting disseminated Mycobacterium avium complex infection |
| US6013510A (en) | 1997-09-25 | 2000-01-11 | Becton, Dickinson And Company | Identification of a DNA region potentially useful for the detection of Mycobacterium kansasii |
| US6294328B1 (en) * | 1998-06-24 | 2001-09-25 | The Institute For Genomic Research | DNA sequences for strain analysis in Mycobacterium tuberculosis |
| IT1303767B1 (it) | 1998-11-17 | 2001-02-23 | San Raffaele Centro Fond | Metodo di quantificazione di acidi nucleici. |
| US6699661B1 (en) | 1999-04-20 | 2004-03-02 | Kankyo Engineering Co., Ltd. | Method for determining a concentration of target nucleic acid molecules, nucleic acid probes for the method, and method for analyzing data obtained by the method |
| CN1151270C (zh) * | 2000-10-31 | 2004-05-26 | 亚能生物技术（深圳）有限公司 | 诊断结核杆菌及其耐药性的dna芯片 |
| CN1491285A (zh) * | 2000-12-26 | 2004-04-21 | �����﹤����ʽ���� | 致病微生物的检测方法 |
| EP1338657B9 (en) * | 2002-02-25 | 2007-10-10 | Institut Pasteur | Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines |
| US20030219757A1 (en) * | 2002-05-24 | 2003-11-27 | Nanibhushan Dattagupta | IS6110 based molecular detection of Mycobacterium tuberculosis |
-
2005
- 2005-04-22 JP JP2006512600A patent/JP4905130B2/ja active Active
- 2005-04-22 US US11/587,510 patent/US8044184B2/en not_active Expired - Fee Related
- 2005-04-22 CN CN201110313194.7A patent/CN102329880B/zh not_active Expired - Fee Related
- 2005-04-22 AT AT05734679T patent/ATE534749T1/de active
- 2005-04-22 WO PCT/JP2005/007700 patent/WO2005103249A1/ja not_active Application Discontinuation
- 2005-04-22 EP EP10174146.0A patent/EP2256218B1/en not_active Not-in-force
- 2005-04-22 ES ES10174146.0T patent/ES2560433T3/es active Active
- 2005-04-22 CN CN2010102952701A patent/CN101935709B/zh not_active Expired - Fee Related
- 2005-04-22 EP EP05734679A patent/EP1746156B1/en not_active Not-in-force
- 2005-04-22 ES ES05734679T patent/ES2375406T3/es active Active
- 2005-04-22 CN CN2005800131204A patent/CN101023170B/zh not_active Expired - Fee Related
-
2011
- 2011-10-25 US US13/281,421 patent/US8628926B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4905130B2 (ja) | 2012-03-28 |
| EP1746156A1 (en) | 2007-01-24 |
| CN102329880B (zh) | 2014-05-14 |
| EP2256218B1 (en) | 2015-12-02 |
| CN101023170A (zh) | 2007-08-22 |
| US20130109013A1 (en) | 2013-05-02 |
| EP1746156B1 (en) | 2011-11-23 |
| US8628926B2 (en) | 2014-01-14 |
| CN101935709B (zh) | 2012-11-28 |
| EP2256218A1 (en) | 2010-12-01 |
| EP1746156A4 (en) | 2008-08-20 |
| ES2560433T3 (es) | 2016-02-19 |
| US20080241826A1 (en) | 2008-10-02 |
| JPWO2005103249A1 (ja) | 2008-03-13 |
| CN102329880A (zh) | 2012-01-25 |
| CN101023170B (zh) | 2011-03-02 |
| US8044184B2 (en) | 2011-10-25 |
| ATE534749T1 (de) | 2011-12-15 |
| WO2005103249A1 (ja) | 2005-11-03 |
| CN101935709A (zh) | 2011-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2375406T3 (es) | Sonda y cebador para la detección de bacilos tuberculosos, y procedimiento para la detección de bacilos tuberculosos humanos con el uso de los mismos. | |
| US9458513B2 (en) | Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same | |
| US8188256B2 (en) | Primer and probe for detection of Mycobacterium intracellulare | |
| ES2357902T3 (es) | Cebadores, sondas, procedimientos y usos de los mismos para la detección de mycobacteriium kansasii. | |
| JP2686428B2 (ja) | マイコバクテリウムカンサシイの種特異的検出 | |
| EP2107114B1 (en) | Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium by using the primer or probe | |
| Han et al. | Molecular bases of high-level streptomycin resistance in Pseudomonas marginalis and Pseudomonas syringae pv. actinidiae | |
| JP5204466B2 (ja) | マイコプラズマ・ニューモニエ（Ｍｙｃｏｐｌａｓｍａｐｎｅｕｍｏｎｉａｅ）の検出方法 | |
| ES2650066T3 (es) | Cebador y sonda para la detección de Mycobacterium intracellulare, y método para la detección de Mycobacterium intracellulare empleando el cebador o la sonda | |
| KR100692484B1 (ko) | 결핵균 및 비결핵항산성균 감별 또는 동정 방법 및 이에사용되는 뉴클레오타이드들 | |
| KR101425149B1 (ko) | 원-튜브 네스티드 실시간 피시알을 이용한 개선된 결핵균 진단방법 | |
| Picardeau et al. | Development of a species-specific probe for Mycobacterium xenopi | |
| JPH06133775A (ja) | ミコバクテリア属微生物のｄｎａＪタンパク質をコードするＤＮＡ、そのＤＮＡを特異的に認識するプローブ及びミコバクテリア属微生物の検出方法 | |
| Koivula et al. | Genetic diversity in clinical isolates of Mycobacterium avium complex from Guinea-Bissau, West Africa | |
| Feng et al. | Establishment of a multiplex PCR system to diagnose tuberculosis and other bacterial infections | |
| JP2006158220A (ja) | マイコプラズマ・ニューモニエ（Ｍｙｃｏｐｌａｓｍａｐｎｅｕｍｏｎｉａｅ）検出のためのオリゴヌクレオチドプライマー | |
| KR20070037238A (ko) | 결핵균 특이 유전자 검출키트 | |
| JPH09103300A (ja) | 結核菌ＲＮＡポリメラーゼβサブユニット遺伝子増幅用オリゴヌクレオチドおよびその用途 | |
| CHOCHOLSKA et al. | UNIVERSITATIS MARIAE CURIE-SKŁODOWSKA LUBLIN—POLONIA | |
| KR20070037240A (ko) | 결핵균 특이 유전자 정량키트 |